Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 110
- 试验地点
- 5
- 主要终点
- Diversity of recruited participants against nine protected characteristics
研究概览
简要总结
Up to one in two adults with type 1 diabetes find living with and managing diabetes to be emotionally challenging. This 'emotional side' of diabetes - feeling worried, frustrated, overwhelmed, sad, burnt-out - is called diabetes distress. It affects people's quality of life and can hinder them from managing their diabetes as well as they can.
In the UK, the NHS needs to better understand how to best support people feeling emotionally burdened by diabetes. So, we have worked with diabetes distress specialists around the world to develop an NHS pathway to care for diabetes distress. This pathway to care involves training diabetes teams to recognise, assess and talk about diabetes distress at routine appointments. If people have a high diabetes distress level, they may be able to take part in an online group program to help them manage their type 1 diabetes and emotions. The feasibility study will test this pathway to care with people with type 1 diabetes in the NHS setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults with type 1 diabetes
- •People aged 18 years old and older
- •With a T1DM diagnosis of more than one year
- •Who used a Continuous Glucose Monitoring device 3 months prior to trial entry
- •Health care professionals
- •Members of the multidisciplinary diabetes team
- •Who would like and be able to undertake training in Enhanced Usual Care (EUC)
- •Family or friend
- •People aged 18 years or older
- •Is involved with the care of the participant
- •The participant has consented to the family member or friend to be involved in the study
- •REDUCE Facilitators
- •Eligibility as per the role specification in Section 6.2.2 of study Protocol
排除标准
- •Adults with type 1 diabetes
- •Exclusion criteria will include those adults diagnosed less than one year ago. This is because the first 12 months following a diagnosis of T1DM is a period of unique stress due to the diagnosis, the acute onset, and requirement to learn complex new skills. Additionally, due to the honeymoon period, which can typically last up to a year, there is variety in the physiological trajectory which might have an impact that would be difficult to measure and account for in this study(Sokołowska, Chobot et al. 2016).
- •Women who are pregnant. This is because the additional burdens and anxieties this population is confronted with may risk confounding the trial findings
- •Exclusion of adults with current mental health diagnoses with current symptoms (e.g. psychosis or substance abuse or severe depression), will be evaluated and determined on a case-by-case basis by clinical care teams.
- •Health care professionals • People who are unwilling or unable to take on additional workload associated with D-stress e-learning and delivery of Enhanced Usual Care.
- •Family or friend
- •Participant with type 1 diabetes has not given consent for a family member or friend to participate in the study
- •REDUCE Facilitators
- •• Professional accreditation with one of the following professional bodies: Nursing & Midwifery Council, Health & Care Professionals Council, British Association for Counselling & Psychotherapy, and UK Council for Psychotherapy.
- •Professional or personal understanding of Type 1 diabetes
- •Professional or personal understanding of NHS diabetes care and guidelines
- •Professional or personal understanding of diabetes distress
- •Professional understanding of mental and emotional health
- •Professional experience of in-person and/or online group facilitation especially in managing diverse needs within a group and the expression of strong emotions
- •Willingness to be a research participant
研究组 & 干预措施
Enhanced Usual Care (EUC)
This arm of the study involves health care professionals e-learning training in and delivery of EUC for the detection and management of diabetes distress.
干预措施: D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes. (Behavioral)
REDUCE Programme Intervention
REDUCE intervention is an online group 6 session programme for the management of elevated diabetes distress.
干预措施: D-stress study: The detection, prevention and management of diabetes distress for adults living with type 1 diabetes. (Behavioral)
结局指标
主要结局
Diversity of recruited participants against nine protected characteristics
时间窗: This primary outcome data will be collected at month 3 baseline data collection and month 6 follow-up data collection.
The study investigators will be assessing the diversity of recruited participants against against nine protected characteristics with the D-stress study specific measurement tool called, the Health and social equalities.
To assess the quality of data collected
时间窗: The study investigators will be collecting data to assess the primary outcome measure at monthly throughout the duration of the 6 month study.
As part of the primary outcome the study investigators will be assessing the quality of data collected via monthly questionnaires using the Acceptability, feasibility and appropriateness of implementation (AIM) (Sturt, Griffiths et al. 2023; Weiner, Lewis 2017), measurement tool realist evaluation process interviews and non-participant observation with study investigators following RAMESES quality and publication standards guidelines (Wong G, Greenhalgh T, Westhorp G, et al. 2013).
Feasibility, service use, acceptability, attrition rate and data quality
时间窗: The study investigators will be collecting data to assess the primary outcome measure at Month 3 and Month 6 of the study.
The main primary outcome measure is to assess the feasibility of the study in relation to progressing to the proposed main trial. As part of the primary outcome the study investigators will be assessing the following: 1. Extent to which of participants find the interventions feasible, and acceptable 2. Proportion of people recruited from those eligible/approached 3. The number of participants who dropped out 4. The quality of the data To conduct these assessments measurements tools used will include: the Acceptability, feasibility and appropriateness of implementation (AIM) (Sturt, Griffiths et al. 2023; Weiner, Lewis 2017), and EQ-5D-5L Quality of Life questionnaire (Feng, Kohlmann et al. 2021). The AIM and EQ-5D-5L measurement tools uses a Likert scale as a unit of measure.
次要结局
- Assessment of initial Realist Process Evaluation programme theories(Conducted over the course of the feasibility study from Day 1 through to the completion of the study, an average of 6 months.)
- Proportion of TIR for interstitial blood glucose (proposed main trial co-primary outcome)(CGM data will be collected monthly from Month 1 through to study completion, an average of 6 months.)
- Diabetes distress score (proposed main trial co-primary outcome)(The T1-DDAS measurement scale will be used every 30 days from Month 1 through to study completion, estimated to be 6 months.)